Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Mol Cancer
; 21(1): 45, 2022 02 11.
Article
in En
| MEDLINE
| ID: mdl-35148751
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Vaccines
/
Cancer Vaccines
/
Exosomes
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Cancer
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
China